Synthesis of texaphyrin conjugates
D. J. Magda, Z. Wang, N. Gerasimchuk, W.-H. Wei, P. Anzenbacher Jr.,
and J. L. Sessler
Pharmacyclics Incorporated, 995 East Arques Avenue,
Sunnyvale, CA
94085-4593 USA
Department of Chemistry & Biochemistry, 1 University Station A5300,
The University of Texas at Austin, Austin, TX 78712-0165, USA
Abstract: This paper summarizes recent synthetic efforts devoted
to the generation of new, second-generation texaphyrin-type drugs, specifically
species that involve known or potential anticancer agents covalently
attached to a tumor-localizing texaphyrin core. Particular emphasis
will be placed on the strategies needed to prepare such systems, as
well as on the choice of active group being subject to attachment.
*Plenary lecture presented at the 2nd Santa Mar�a Workshop
on Chemistry Devoted to Bioinorganic Chemistry, Santa Mar�a del Mar,
Havana, Cuba, 7-11 July 2003. Other presentations are published in this
issue, pp. 321-388.
Page last modified 3 April 2004.
Copyright © 2004 International Union of Pure and Applied Chemistry.
Questions or comments about IUPAC, please contact, the Secretariat.
Questions regarding the website, please contact web
manager.
